Forward P/S Multiple: Aethlon Medical, Inc. (AEMD)
Aethlon Medical (AEMD) is striving to optimize its global filter distribution networks to maintain high margins. The forward price-to-sales ratio on the GURU.Markets chart demonstrates progress toward this goal, with the metric holding at 9.60. However, geopolitical sanctions and the clinical trial stage of the Hemopurifier for oncology treatment create certain obstacles to rapid business scaling.
Summary analytical data breakdowns for Aethlon Medical Corp (AEMD)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Aethlon Medical|AEMD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Aethlon Medical|AEMD - Company Aggregate Debts|Debt to Book Capitalization Ratio Aethlon Medical Corp|AEMD - Company Long-Term Debt|Company Current Liabilities Aethlon Medical|Quick Ratio aethlonmedical.com
- financial results and valuation multiples details:
AEMD - Company Net Income|Expected Profit Aethlon Medical|AEMD - Market Cap to Net Income Ratio|Projected Price to Earnings Aethlon|AEMD - PEG Multiple|EV/EBITDA Multiple Aethlon Medical Corp|AEMD - Operating income before deduction of amortization|Earnings per share for the last twelve months Aethlon Medical|AEMD - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months aethlonmedical.com|AEMD - Net earnings per share growth this year|Earnings growth forecast for next year Aethlon Medical
- sales and revenue indicators:
Fundamental company analysis:AEMD (Aethlon Medical, Inc.)
To build a defensive portfolio, fundamental screening requires an analysis of the market capitalization to expected revenue ratio, which allows for the valuation of future cash flows. Since Aethlon Medical (AEMD) is in the clinical testing stage without pricing power, the forward price-to-sales ratio reflects the market's speculative expectations regarding the commercial success of the equipment.
Who Aethlon Medical competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|Beyond Air (XAIR) - Forward P/S Multiple|PFSA (Profusa) - Forward P/S Multiple|Market Cap to Future Revenue Ratio STRATA Skin SSKN|Forward Price-to-Revenue Multiple GCTK (GlucoTrack)|Price to Expected Revenue Ratio NAOV|Forward P/S Multiple VERO (Venus Concept Inc.)|Forward Price to Sales NUWE|ASXC - Price-to-Projected Revenue Ratio|AVGR: Price-to-Projected Revenue Ratio|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Cutera Inc (CUTR)|Price-to-Projected Revenue Ratio Know Labs, Inc.|Market Cap to Projected Revenue NARI (inarimedical.com)|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK
